Skip to content

Determination of the Glycemic Index (GI) According to the ISO 26642:2010 Standard Guidelines in meal replacement products

Determination of the Glycemic Index (GI) According to the ISO 26642:2010 Standard Guidelines in meal replacement products

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260210003
Enrollment
15
Registered
2026-02-10
Start date
2026-03-09
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer Healthy volunteer

Interventions

Experimental No treatment

Sponsors

Amway (Thailand) Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Male or female participants aged 20 to 60 years, 2. Body mass index between 18.5 and 25 kilograms per square meter, 3. Healthy individuals with no underlying diseases as assessed by laboratory analyses including insulin HOMA IR HbA1c fasting blood glucose total cholesterol and complete blood count, 4. Non smokers and not regular alcohol consumers, 5. Individuals without diabetes and not currently receiving anti diabetic medication, 6. Individuals with normal fasting blood sugar levels below 100 milligrams per deciliter, 7. Female participants must use effective contraception throughout the study period, 8. Individuals who are willing to participate in the research study and provide written informed consent

Exclusion criteria

Exclusion criteria: 1. Individuals with a history of allergy to soy milk legume proteins or cow milk, 2. Individuals with a history of systemic illnesses such as diabetes cardiovascular diseases kidney lung endocrine or neurological disorders chronic or active infectious diseases such as HBV HCV or HIV peptic ulcer disease autoimmune diseases skin diseases or food allergies, 3. Individuals consuming foods or medications that affect glucose metabolism including antipsychotic drugs, 4. Individuals with a history of serious illness surgery or hospitalization within the past three months, 5. Individuals following specific or restrictive diets such as ketogenic paleo or medically indicated vegetarian diets will not be eligible for participation to ensure consistency of metabolic responses and to maintain the validity of the study, 6. Individuals regularly using steroid medications protease inhibitors or psychiatric medications which may affect glucose metabolism or body fat distribution, 7. Individuals who have consumed medications herbal products or dietary supplements that affect blood glucose levels within one month prior to the study, 8. Pregnant or breastfeeding women, 9. Individuals who have participated in another research study within the past thirty days such as studies involving consumption of products with blood glucose monitoring as a primary outcome

Design outcomes

Primary

MeasureTime frame
Incremental area under the curve 15, 30, 45, 60, 90, 120 min 2 postprandial glucose

Secondary

MeasureTime frame
Body composition 8 visits Body composition analyser

Countries

Thailand

Contacts

Public ContactKongsak Boonyapranai

Research Institute for Health Sciences

kongsak.b@cmu.ac.th0922717217

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026